Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00055_DB06684_nanopub.RA3BP-Z7WH5ToF2XZWHFEpBcQtzS4_5Iw-uTZ40ZweJ_U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00055_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00055_DB06684 label "DDI between Drotrecogin alfa and Vilazodone - Increase monitoring for signs/symptoms of bleeding during concomitant therapy. If possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents. [drugbank_resource:DB00055_DB06684]" assertion.
- drugbank_resource:DB00055_DB06684 identifier "drugbank_resource:DB00055_DB06684" assertion.
- drugbank_resource:DB00055_DB06684 title "DDI between Drotrecogin alfa and Vilazodone - Increase monitoring for signs/symptoms of bleeding during concomitant therapy. If possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents." assertion.
- drugbank:DB06684 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00055_DB06684 assertion.
- drugbank:DB00055 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00055_DB06684 assertion.